Medical Device News Magazine

Department of Defense Adds Lipogems to Their Arsenal

Premier Medical Technology Available To Order Through DAPA

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Musculoskeletal injuries pose the greatest public health problem facing military service members during peacetime and combat. Musculoskeletal issues impact approximately 800,000 service members annually and are the greatest threat to military readiness and the primary reason for medical discharge.

The company Lipogems, is a leading global medical technology company. Today they announced that, through its partnership with Buffalo Supply, Inc., the Lipogems Sports Medicine System is now available within the U.S. Department of Defense (DoD) to help over 2.3 million service members that may be suffering from orthopaedic and wound issues.

Lipogems is a premier FDA-cleared medical technology that uses the patient’s own adipose tissue (fat) and injects it into troubled areas to support the repair and healing of injured or damaged tissue.  The simple, minimally invasive procedure uses only a local anesthetic and can be performed in the clinic, on the field, or added to surgery. For veterans with multiple issues, the fat from one harvest can be used in multiple areas in the same setting. Through the Distribution And Pricing Agreement (DAPA), Lipogems is now available at over 60 hospitals and over 400 clinics, and 2 hospital ships (USNS Mercy, USNS Comfort).

“We are proud and honored to be helping our nation’s brave active military and veterans. Currently, Lipogems is being used by military physicians with great success to help those that have tried conservative options with limited relief for their orthopaedic issues and are not ready for major invasive surgery. DAPA provides better access to the DoD medical facilities and efficient means of supporting the military for their orthopaedic, wound, and burn issues. As a responsible company, Lipogems is supported by strong scientific and clinical evidence with over 70+publications in peer-reviewed journals from leading institutions from around the world. We would like to recognize and thank the Geneva Foundation for the MIRROR Study evaluating Lipogems for knee issues in active military patients and Brooke Army Medical Center for evaluating Lipogems for wound victims. Also, we would like to thank the multiple orthopaedic physicians that have donated the Lipogems procedure to retired Special Operations, veterans, and active military. Our veterans deserve the best access to healthcare and we are proud to help the heroic men and women who serve our country.” Said Carl Llewellyn, CEO, and President of Lipogems USA. Additional information available here.

 

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”